Table 1 Adenoid cystic carcinoma (ACC) and liver patient plans characteristics summarizing the numbers and sizes of clinical tumor volumes, fractionation schemes (number and dose per fraction), numbers of fields, and organs at risk considered during the plan optimization.

From: Potential benefits of using radioactive ion beams for range margin reduction in carbon ion therapy

Tumor

Patient ID

Target

VCTV, cm3

Fractions

Fraction dose, Gy(RBE)

No. fields

OARs considered

ACC

1

a

340.4

20

3

2

Optic system (eyes, nerves, chiasm), brainstem

2

336.7

3

199.9

4

206.8

5

245.6

6

53.4

7

350.2

8

747.9

9

316.9

10

351.0

11

201.0

12

343.3

13

462.3

14

294.9

15

215.5

Liver

1

a

30.0

4

10

1

Right kidney and lung

2

a

16.1

4

10

1

 

3

a

17.4

4

10

1

 

4

a

12.2

6

7

2

Small bowel, colon

5

a

70.6

4

10

1

 

6

a

198.2

6

7

2

Right lung, duodenum

b

24.6

6

7

1

7

a

40.2

4

10

1

 

8

a

162.2

6

7

1

Large bowel, heart

9

a

60.0

4

10

1

Right kidney

b

38.0

4

10

1

c

32.8

4

10

1

10

a

7.8

4

10

1